Navigation Links
Dr. Robert D. Willix Jr. M.D., CEO and CMO of Cenegenics(R) Medical Institute of Boca Raton Appointed Chief Medical Officer of Cenegenics(R) Medical Institute, World's Largest Preventive Age Management Practice
Date:1/13/2010

LAS VEGAS, Jan. 13 /PRNewswire/ -- Dr. Robert D. Willix Jr., CEO and Chief Medical Officer of Cenegenics® Medical Institute of Boca Raton, and 2009 recipient of the Alan P. Mintz Award for Clinical Excellence in Age Management Medicine, has been appointed Chief Medical Officer for Cenegenics® Medical Institute.    

(Photo: http://www.newscom.com/cgi-bin/prnh/20100113/FL36991 )

The appointment marks a new approach to medical leadership for Cenegenics®, currently the nation's largest and fastest growing age management/preventive medical institute with medical centers throughout the United States, and new centers opening in Chicago, Los Angeles, Philadelphia and Washington, D.C. this month.

As CMO at Cenegenics®, Willix will implement new age management preventive medical technologies and therapies to impact the lives of Americans and how they age.  Research will concentrate on telomeres, stem cell therapies, new analysis for nutritional markers, non-hormonal derived therapies for women, new markers for aging, diagnostics and quality assurance programs to maintain a standardization of care.

"I am honored to accept this position of Chief Medical Officer and look forward to this new chapter in medical leadership for Cenegenics®, which continues to keep preventive age management medicine at the forefront of the medical community," remarks Willix.  "The fast-paced growth of Cenegenics® in our nation's preventive health care arena is indicative of the paradigm shift in medicine for which Cenegenics® is responsible."  

About Cenegenics®:

Established in 1997, Cenegenics® Medical Institute has developed the largest age management and preventive medicine practice in the world with centers in Boca Raton, Florida; Las Vegas, Nevada; Charleston, South Carolina; Dallas and Fort Worth, Texas; Los Angeles, California, Chicago, Illinois, Washington DC; Atlanta, Georgia.  With a recognized presence in the medical community, Cenegenics® incorporates a proactive, preventive approach based on solid science and a comprehensive evaluation. For more information about Cenegenics® Boca Raton, visit www.cenegenics-br.com or call 561-362-0724.  

To schedule a media interview, please contact Michelle Soudry at The Gab Group at 561-750-3500 or by emailing msoudry@thegabgroup.com

SOURCE Cenegenics Medical Institute

RELATED LINKS
http://www.cenegenics-br.com

'/>"/>

SOURCE Cenegenics Medical Institute
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
2. Robert J. Heine, M.D., Ph.D., F.R.C.P. to Join Lilly; Distinguished Diabetes Expert to Lead Diabetes/Endocrine Medical Division
3. Statement by Robert Greenstein, Executive Director of the Center on Budget and Policy Priorities, on the New Congressional SCHIP Agreement
4. Cardinal Health Names CEO R. Kerry Clark as Chairman; Company Founder Robert D. Walter to Retire After 36 Years
5. Trust for Americas Health Receives $7.6 Million Grant from the Robert Wood Johnson Foundation to Advance the Quality and Impact of the Public Health System
6. Wyeth Announces the Election of Robert M. Amen to Its Board of Directors
7. Mylan Vice Chairman and CEO Robert J. Coury to Ring NYSE Closing Bell(R) in Celebration of Merck Generics Acquisition
8. Robert Wood Johnson Foundation Announces $15.6 Million Grant to Apply Power of the Archimedes Model to Critical Health Care Decisions
9. Roper Industries to Present at the Robert W. Baird Industrial Conference
10. Schering-Plough to Webcast CFO Robert J. Bertolinis Presentation at 2007 Credit Suisse Health Care Conference
11. Verus Pharmaceuticals Announces Promotion of Robert W. Keith to Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... ... as the World Molecular Imaging Congress (WMIC), will be held in New York ... meeting is “Imaging Biology…Improving Therapy.” The congress will highlight and emphasize how imaging ...
(Date:2/10/2016)... Rancho Mirage, California (PRWEB) , ... February 10, ... ... Care Dental are working together to expand dental health services to the developmentally ... have moved We Care Dental’s operations to a new facility at 71-949 Highway ...
(Date:2/10/2016)... ... February 10, 2016 , ... Compliancy ... to associations of medical professionals throughout the country. The Guard was specifically designed ... policies and procedures, employee training, regulatory updates, and compliance coaching. , In addition ...
(Date:2/10/2016)... Thornton, CO (PRWEB) , ... February 10, 2016 , ... ... to announce the practice is now accepting new dental patients and families in the ... expect exceptional dental care services from cleanings to cosmetic dentistry, and all in the ...
(Date:2/10/2016)... ... ... AxoGen, Inc. (NASDAQ: AXGN), a leading medical technology company focused on the peripheral ... December 31, 2015 on Monday, February 29, 2016 after the market closes. , The ... release at 4:30 PM ET. Investors interested in participating by phone are invited to ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... 2016  The ALS Association, in partnership with ALS Finding ... generate a biomarker to track TDP43 aggregation. The successful team(s) ... $1 million investment. --> ... nerve cells in the brain and the spinal cord. Eventually, ... muscle movement, which often leads to total paralysis and death ...
(Date:2/10/2016)... , Feb. 10, 2016  LexisNexis® Risk ... technology, today announced the launch of LexisNexis ... solution that helps improve and optimize the quality ... of performance using severity-adjusted scores. By measuring provider ... critical solution to deliver better outcomes, improve the ...
(Date:2/10/2016)... CORAL SPRINGS, Florida , February 10, 2016 ... Adamas Pharmaceuticals, Inc. (NASDAQ: ADMS ) and Celldex Therapeutics, ... Medivation, Inc. (NASDAQ: MDVN ), Adamas Pharmaceuticals, Inc. (NASDAQ: ... ). --> Today,s latest Orphan Drug Designations become ... granted by the FDA to novel drugs and biologics which ...
Breaking Medicine Technology: